OSL:TRMED - Euronext Oslo - NO0010597883 - Common Stock - Currency: NOK
OSL:TRMED (4/25/2025, 7:00:00 PM)
2.4
-0.06 (-2.24%)
The current stock price of TRMED.OL is 2.4 NOK. In the past month the price decreased by -8.4%. In the past year, price increased by 122.22%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 18.11 | 285.16B | ||
AMG.DE | AMGEN INC | 14.09 | 131.97B | ||
GIS.DE | GILEAD SCIENCES INC | 22.32 | 112.70B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | 1723.6 | 110.78B | ||
ARGX.BR | ARGENX SE | 352.5 | 32.72B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 24.54B | ||
IDP.DE | BIOGEN INC | 7.17 | 15.20B | ||
0QF.DE | MODERNA INC | N/A | 9.45B | ||
1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
BIO.DE | BIOTEST AG | 24.8 | 1.68B | ||
GLPG.AS | GALAPAGOS NV | N/A | 1.54B | ||
BIO3.DE | BIOTEST AG-VORZUGSAKTIEN | 17.54 | 1.19B |
Thor Medical ASA.engages in the producing and supplying alpha particle emitters for cancer therapy. The company is headquartered in Oslo, Oslo and currently employs 9 full-time employees. The company went IPO on 2014-07-07. The firm is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The firm is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The firm has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells
THOR MEDICAL ASA
Karenslyst alle 9C
Oslo OSLO NO
Employees: 5
Company Website: https://www.thormedical.no/
Investor Relations: https://www.thormedical.no/investor-relations/ir-contact
Phone: 4797414000
The current stock price of TRMED.OL is 2.4 NOK. The price decreased by -2.24% in the last trading session.
The exchange symbol of THOR MEDICAL ASA is TRMED and it is listed on the Euronext Oslo exchange.
TRMED.OL stock is listed on the Euronext Oslo exchange.
THOR MEDICAL ASA (TRMED.OL) has a market capitalization of 754.58M NOK. This makes TRMED.OL a Small Cap stock.
THOR MEDICAL ASA (TRMED.OL) currently has 5 employees.
THOR MEDICAL ASA (TRMED.OL) has a support level at 2.39 and a resistance level at 2.51. Check the full technical report for a detailed analysis of TRMED.OL support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TRMED.OL does not pay a dividend.
THOR MEDICAL ASA (TRMED.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.15).
ChartMill assigns a technical rating of 5 / 10 to TRMED.OL. When comparing the yearly performance of all stocks, TRMED.OL is one of the better performing stocks in the market, outperforming 96.32% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TRMED.OL. TRMED.OL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months TRMED.OL reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 94.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -8.3% | ||
ROE | -10.22% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 34% to TRMED.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.